Covaxin priced at Rs 600 for States, Rs 1200 for private hospitals

The pharma company stated that Covaxin will also be exported and the price would be between $15-20 ( Rs 1,123 to RS 1,498 approximately).

"Bharat Biotech is honored to develop, manufacture and supply Covaxin for India's vaccine rollout of Rs 150/dose, which is distributed for free by the Government of India. We would like to state that more than 50 percent of our capacities have been reserved for Central Government supplies," said Dr Krishna Ella, Chairman & Managing Director, Bharat Biotech.

In a statement, Bharat Biotech chairman and managing director Krishna M Ella said, "Recovering costs is essential in the journey of innovation towards other vaccines such as Intranasal Covid-19...Our core mission for the last 25 years has been to provide affordably, yet world-class healthcare solutions for the globe."

On April 21 Serum Institute of India announced that its COVID19 vaccine Covishield will be sold at Rs 400 a shot to states and Rs 600 to private hospitals, days ahead of the next phase of vaccinations from May 1 which will inoculate everyone above the age of 18 after Central Government on Monday announced liberalized vaccination policy. The pharma company will continue to sell vaccine doses to centers for Rs 150 each.

SII also said that it will sell the Covishield vaccine to private hospitals for Rs 600. They added its vaccines will still be more affordable than foreign jabs, which cost anywhere from Rs 750 to Rs 1,500 a shot.

As part of the government's new policy, 50 percent of the vaccine doses will be reserved for the centre and the rest will be divided between states and private hospitals which means it will be cheapest to get a vaccine shot from central government hospitals or establishments.

The pharma company said that the company will serve 50 percent of the total production to the Government of India's vaccination program, and the remaining 50 percent of the capacity will be for the State governments and private hospitals.